Skip to content

Author

L. Yousif

We have 3 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Cardioprotective effects of medical therapy for cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis

It is hypothesized that severity of established CTRCD in this subgroup might be too advanced for significant LVEF improvements, and statins hold promise in the prevention of anthracycline- and/or anti-HER2-mediated CTRCD, whereas no beneficial effect was observed in patients with combination regimens.

Y. Appels, R. Parvan, C. G. Mohan et al. · 0 citations
Review Aug 2026

Impact of cardiovascular disease on cancer incidence and mortality

The manifold of CVD and CV health indicators increase the risk of new-onset cancer and cancer-related mortality, and the need for awareness of future cancer in patients with CVD is emphasized.

L. Yousif, P. Ameri, M. Vinci et al. · 0 citations
Aug 2026

Elevated levels of PD-L1 are associated with rs72705424 and increased risk of incident cardiovascular disease in the UK Biobank

Findings indicate that the variant rs72705424 is associated with higher circulating PD-L1 levels and that elevated PD-L1 increases the risk of incident CVD, and highlight how genetic variation can affect circulating factors and the subsequent CVD risks.

A. Sijtema, L. Yousif, M. Asik et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.